Atlas Trials

Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Clinical trial NCT02738632 · COMPLETED

Trial details

NCT number
NCT02738632
Sponsor
IlDong Pharmaceutical Co Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2015-05-01
Primary completion
2016-08-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.